tiprankstipranks
Lung Kee (Bermuda) Holdings Limited (HK:0255)
:0255
Hong Kong Market
Want to see HK:0255 full AI Analyst Report?

Lung Kee (Bermuda) Holdings Limited (0255) Stock Statistics & Valuation Metrics

2 Followers

Total Valuation

Lung Kee (Bermuda) Holdings Limited has a market cap or net worth of HK$982.71M. The enterprise value is HK$398.25M.
Market CapHK$982.71M
Enterprise ValueHK$398.25M

Share Statistics

Lung Kee (Bermuda) Holdings Limited has 634,007,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding634,007,300
Owned by Insiders
Owned by Institutions

Financial Efficiency

Lung Kee (Bermuda) Holdings Limited’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is -2.07%.
Return on Equity (ROE)-0.01
Return on Assets (ROA)-0.01
Return on Invested Capital (ROIC)-2.07%
Return on Capital Employed (ROCE)-0.03
Revenue Per Employee439.97K
Profits Per Employee-7.54K
Employee Count3,000
Asset Turnover0.73
Inventory Turnover2.70

Valuation Ratios

The current PE Ratio of Lung Kee (Bermuda) Holdings Limited is ―. Lung Kee (Bermuda) Holdings Limited’s PEG ratio is -0.73.
PE Ratio
PS Ratio0.82
PB Ratio0.70
Price to Fair Value0.70
Price to FCF6.24
Price to Operating Cash Flow4.67
PEG Ratio-0.73

Income Statement

In the last 12 months, Lung Kee (Bermuda) Holdings Limited had revenue of 1.32B and earned -22.62M in profits. Earnings per share was -0.04.
Revenue1.32B
Gross Profit268.35M
Operating Income-49.75M
Pretax Income-33.15M
Net Income-22.62M
EBITDA108.90M
Earnings Per Share (EPS)-0.04

Cash Flow

In the last 12 months, operating cash flow was 210.25M and capital expenditures -40.03M, giving a free cash flow of 170.22M billion.
Operating Cash Flow210.25M
Free Cash Flow170.22M
Free Cash Flow per Share0.27

Dividends & Yields

Lung Kee (Bermuda) Holdings Limited pays an annual dividend of HK$0.08, resulting in a dividend yield of 14.77%
Dividend Per ShareHK$0.08
Dividend Yield14.77%
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.38
52-Week Price Change33.62%
50-Day Moving Average1.47
200-Day Moving Average1.58
Relative Strength Index (RSI)58.04
Average Volume (3m)41.87K

Important Dates

Lung Kee (Bermuda) Holdings Limited upcoming earnings date is Aug 21, 2026, TBA (Not Confirmed).
Last Earnings DateMar 20, 2026
Next Earnings DateAug 21, 2026
Ex-Dividend Date

Financial Position

Lung Kee (Bermuda) Holdings Limited as a current ratio of 6.13, with Debt / Equity ratio of 0.28%
Current Ratio6.13
Quick Ratio3.97
Debt to Market Cap<0.01
Net Debt to EBITDA-5.37
Interest Coverage Ratio-161.02

Taxes

In the past 12 months, Lung Kee (Bermuda) Holdings Limited has paid -10.53M in taxes.
Income Tax-10.53M
Effective Tax Rate0.32

Enterprise Valuation

Lung Kee (Bermuda) Holdings Limited EV to EBITDA ratio is 4.56, with an EV/FCF ratio of 2.86.
EV to Sales0.38
EV to EBITDA4.56
EV to Free Cash Flow2.86
EV to Operating Cash Flow2.33

Balance Sheet

Lung Kee (Bermuda) Holdings Limited has HK$588.63M in cash and marketable securities with HK$4.36M in debt, giving a net cash position of HK$584.28M billion.
Cash & Marketable SecuritiesHK$588.63M
Total DebtHK$4.36M
Net CashHK$584.28M
Net Cash Per ShareHK$0.92
Tangible Book Value Per ShareHK$2.45

Margins

Gross margin is 40.99%, with operating margin of -3.77%, and net profit margin of -1.71%.
Gross Margin40.99%
Operating Margin-3.77%
Pretax Margin-2.51%
Net Profit Margin-1.71%
EBITDA Margin8.25%
EBIT Margin-3.77%

Analyst Forecast

The average price target for Lung Kee (Bermuda) Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast-15.02%
EPS Growth Forecast-65.74%

Scores

Smart Score6
AI Score